EBIT: Income before interest and taxes.
Teva Pharmaceutical Industries Ltd. (TEVA) had EBIT of $652.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$3.98B |
|
$369.00M |
|
$2.01B |
|
$1.97B |
|
$3.33B |
|
$652.00M |
|
$-216.00M |
|
$437.00M |
|
$437.00M |
|
$370.00M |
|
$369.00M |
|
$369.00M |
|
$370.00M |
|
|
EBIT |
$652.00M |
$891.00M |
|
1.16B |
|
1.18B |
|
$0.32 |
|
$0.31 |
|
| Balance Sheet Financials | |
$13.71B |
|
$4.00B |
|
$26.33B |
|
$40.04B |
|
$13.53B |
|
$14.02B |
|
$18.28B |
|
$31.81B |
|
$8.23B |
|
$-11.20B |
|
$8.23B |
|
1.16B |
|
| Cash Flow Statement Financials | |
$-40.00M |
|
$229.00M |
|
$13.00M |
|
$3.56B |
|
$3.74B |
|
$185.00M |
|
$43.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
0.63 |
|
2.02 |
|
49.52% |
|
16.37% |
|
16.37% |
|
-- |
|
10.97% |
|
9.27% |
|
$-166.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.63 |
|
1.17 |
|
76.69 |
|
4.48% |
|
-3.29% |
|
0.92% |
|
1.66% |
|
$7.07 |
|
$-0.14 |
|
$-0.03 |
|